These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16247339)

  • 1. Second generation antipsychotics--aripiprazole revisited.
    Med Lett Drugs Ther; 2005 Oct; 47(1219):81-2. PubMed ID: 16247339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
    Crismon ML; DeLeon A; Miller AL
    Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole-related body-weight gain and nutritional counseling.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E44-5. PubMed ID: 21677226
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole (Abilify) for schizophrenia.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):15-6. PubMed ID: 12592215
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fewer side effects and lower mortality from modern antipsychotic drugs. But they are more expensive than older antipsychotics, based on a study from Västra Götaland].
    Björling G; Wilhelmsen L; Björnberg A; Odén A; Welin L
    Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1350-3. PubMed ID: 22913117
    [No Abstract]   [Full Text] [Related]  

  • 7. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 8. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J
    Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of aripiprazole in early onset schizophrenia: safety and efficacy.
    Normala I; Hamidin A
    Med J Malaysia; 2009 Sep; 64(3):240-1. PubMed ID: 20527278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    Kim SH; Ivanova O; Abbasi FA; Lamendola CA; Reaven GM; Glick ID
    J Clin Psychopharmacol; 2007 Aug; 27(4):365-8. PubMed ID: 17632220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expectations and developments in atypical antipsychotics].
    Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.
    Stahl SM
    J Clin Psychiatry; 2001 Dec; 62(12):923-4. PubMed ID: 11780870
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole in chronic schizophrenia: experiences in daily practice.
    Fernald DS; van Dellen RT; Hovens JE; Loonen AJ
    Acta Psychiatr Scand; 2006 Oct; 114(4):294; author reply 294. PubMed ID: 16968370
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials.
    Kane JM; Kim E; Kan HJ; Guo Z; Bates JA; Whitehead R; Pikalov A
    Appl Health Econ Health Policy; 2009; 7(2):109-19. PubMed ID: 19731968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.